We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Require Labeling Content Submissions in SPL Format on Oct. 31
FDA to Require Labeling Content Submissions in SPL Format on Oct. 31
October 11, 2005
Beginning at the end of the month, the FDA will require drugmakers to adopt the structured product language (SPL) format for certain human drug labeling submissions, according to an agency official.